In vivo restoration of laminin 5 β3 expression and function in junctional epidermolysis bullosa

The blistering disorder, lethal junctional epidermolysis bullosa (JEB), can result from mutations in the LAMB3 gene, which encodes laminin 5 β3 (β3). Appropriate expression of LAMβ3 in JEB skin tissue could potentially ameliorate the symptoms of the underlying disease. To explore the utility of this therapeutic approach, primary keratinocytes from six unrelated JEB patients were transduced with a retroviral vector encoding β3 and used to regenerate human skin on severe combined immunodeficient (SCID) mice. Tissue regenerated from β3-transduced JEB keratinocytes produced phenotypically normal skin characterized by sustained β3 expression and the formation of hemidesmosomes. Additionally, β3 gene transfer corrected the distribution of a number of important basement membrane zone proteins including BPAG2, integrins β4/β1, and laminins α3/γ2. Skin produced from β3-negative (β3[−]) JEB cells mimicked the hallmarks of the disease state and did not exhibit any of the aforementioned traits. Therefore, by effecting therapeutic gene transfer to β3-deficient primary keratinocytes, it is possible to produce healthy, normal skin tissue in vivo. These data support the utility of gene therapy for JEB and highlight the potential for gene delivery in the treatment of human genetic skin disease.

[1]  R. Burgeson,et al.  Bone Morphogenetic Protein 1 Is an Extracellular Processing Enzyme of the Laminin 5 γ2 Chain* , 2000, The Journal of Biological Chemistry.

[2]  J. Uitto,et al.  The DEBRA International Visioning/Consensus Meeting on Epidermolysis Bullosa: summary and recommendations. , 2000, The Journal of investigative dermatology.

[3]  D. Kohn,et al.  Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. , 1999, Blood.

[4]  Y. Takada,et al.  α3β1 Adhesion to Laminin-5 and Invasin: Critical and Differential Role of Integrin Residues Clustered at the Boundary between α3 N-Terminal Repeats 2 and 3† , 1999 .

[5]  M. Marinkovich,et al.  Update on inherited bullous dermatoses. , 1999, Dermatologic clinics.

[6]  L. Taichman,et al.  In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy , 1999, Gene Therapy.

[7]  W. Carter,et al.  Targeted Disruption of the LAMA3 Gene in Mice Reveals Abnormalities in Survival and Late Stage Differentiation of Epithelial Cells , 1999, The Journal of cell biology.

[8]  D. Roop,et al.  Transduction of a preselected population of human epidermal stem cells: consequences for gene therapy. , 1999, Proceedings of the Association of American Physicians.

[9]  S. Weitzman,et al.  A Cell Signal Pathway Involving Laminin-5, α3β1 Integrin, and Mitogen-activated Protein Kinase Can Regulate Epithelial Cell Proliferation , 1999 .

[10]  P. Khavari,et al.  BP180 gene delivery in junctional epidermolysis bullosa , 1999, Gene Therapy.

[11]  J. Falk-Marzillier,et al.  Characterization of a Tight Molecular Complex between Integrin α6β4 and Laminin-5 Extracellular Matrix☆☆☆ , 1998 .

[12]  M. Akiyama Severe congenital ichthyosis of the neonate , 1998, International journal of dermatology.

[13]  D. Kohn,et al.  Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Sonnenberg,et al.  Hemidesmosome Formation Is Initiated by the β4 Integrin Subunit, Requires Complex Formation of β4 and HD1/Plectin, and Involves a Direct Interaction between β4 and the Bullous Pemphigoid Antigen 180 , 1998, The Journal of cell biology.

[15]  F. Watt,et al.  Optimised retroviral infection of human epidermal keratinocytes: long-term expression of transduced integrin gene following grafting on to SCID mice , 1998, Gene Therapy.

[16]  S. Hopkinson,et al.  Structure and assembly of hemidesmosomes , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[17]  J. Garlick,et al.  Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Stack,et al.  Processing of Laminin-5 and Its Functional Consequences: Role of Plasmin and Tissue-type Plasminogen Activator , 1998, The Journal of cell biology.

[19]  P. Khavari Gene therapy for genetic skin disease. , 1998, The Journal of investigative dermatology.

[20]  P. Khavari,et al.  Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB , 1998 .

[21]  C. Nielsen,et al.  Systematics: Sequences lead to tree of worms , 1998, Nature.

[22]  M. KolodkaT,et al.  in vitroでのケラチノサイト幹細胞の証拠 レトロウイルス導入ケラチノサイトの長期移植とトランス遺伝子発現持続 , 1998 .

[23]  P. Khavari,et al.  Abnormal transglutaminase 1 expression pattern in a subset of patients with erythrodermic autosomal recessive ichthyosis. , 1998, The Journal of investigative dermatology.

[24]  P. Khavari,et al.  Sustainable cutaneous gene delivery , 1997, Nature Biotechnology.

[25]  J. Uitto,et al.  Epidermolysis bullosa: a spectrum of clinical phenotypes explained by molecular heterogeneity. , 1997, Molecular medicine today.

[26]  G. Zambruno,et al.  A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. , 1997, The Journal of clinical investigation.

[27]  J. Uitto,et al.  Homozygous alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. , 1997, Human molecular genetics.

[28]  R. Unterhuber German law clashes with state of reproductive medicine , 1997, Nature Medicine.

[29]  G. Nolan,et al.  Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes. , 1996, Human gene therapy.

[30]  P. Khavari,et al.  Corrective gene transfer in the human skin disorder lamellar ichthyosis , 1996, Nature Medicine.

[31]  V. Quaranta,et al.  Laminin-5 and hemidesmosomes: role of the alpha 3 chain subunit in hemidesmosome stability and assembly. , 1996, Journal of cell science.

[32]  G. Nolan,et al.  Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. , 1996, Human gene therapy.

[33]  E. Fuchs,et al.  Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival , 1996, The Journal of cell biology.

[34]  G. Yehia,et al.  Absence of integrin α6 leads to epidermolysis bullosa and neonatal death in mice , 1996, Nature Genetics.

[35]  J. Uitto,et al.  Mutational hotspots in the LAMB3 gene in the lethal (Herlitz) type of junctional epidermolysis bullosa. , 1996, Human molecular genetics.

[36]  E. Bauer,et al.  The Assembly of Laminin-5 Subunits (*) , 1995, The Journal of Biological Chemistry.

[37]  J. R. McMillan,et al.  Mutations in the 180–kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa , 1995, Nature Genetics.

[38]  J. Uitto,et al.  Integrin β4 mutations associated with junctional epidermolysis bullosa with pyloric atresia , 1995, Nature Genetics.

[39]  S. Bale,et al.  The genetics of ichthyosis: a primer for epidemiologists. , 1994, The Journal of investigative dermatology.

[40]  R. Burgeson,et al.  The complete primary structure for a novel laminin chain, the laminin B1k chain. , 1994, The Journal of biological chemistry.

[41]  J. Uitto,et al.  Mutations in the γ2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa , 1994, Nature Genetics.

[42]  J. Uitto,et al.  Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the γ2 subunit of nicein/kalinin (LAMININ–5) , 1994, Nature Genetics.

[43]  R. Burgeson,et al.  Cellular origin of the dermal‐epidermal basement membrane , 1993, Developmental dynamics : an official publication of the American Association of Anatomists.

[44]  K. Owaribe,et al.  HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. , 1993, Journal of biochemistry.

[45]  R. Burgeson,et al.  The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. , 1992, The Journal of biological chemistry.

[46]  Y. Barrandon,et al.  Three clonal types of keratinocyte with different capacities for multiplication. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Rice,et al.  Keratinocyte-specific transglutaminase of cultured human epidermal cells: Relation to cross-linked envelope formation and terminal differentiation , 1985, Cell.

[48]  Thomas B. Fitzpatrick,et al.  Dermatology in general medicine , 1971 .